Metabolites Analysis of Anti-Myocardial Ischemia Active Components of Saussurea involucrata Based on Gut Microbiota—Drug Interaction
Open Access
- 5 July 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (13) , 7457
Abstract
Saussurea involucrata has been reported to have potential therapeutic effects against myocardial ischemia. The pharmacological effects of oral natural medicines may be influenced by the participation of gut microbiota. In this study, we aimed to investigate the bidirectional regulation of gut microbiota and the main components of Saussurea involucrata. We first established a quantitative method for the four main components (chlorogenic acid, syringin, acanthoside B, rutin) which were chosen by fingerprint using liquid chromatography tandem mass spectrometry (LC-MS/MS), and found that gut microbiota has a strong metabolic effect on them. Meanwhile, we identified five major rat gut microbiota metabolites (M1–M5) using liquid chromatography tandem time-of-flight mass spectrometry (LC/MSn-IT-TOF). The metabolic properties of metabolites in vitro were preliminarily elucidated by LC-MS/MS for the first time. These five metabolites of Saussurea involucrata may all have potential contributions to the treatment of myocardial ischemia. Furthermore, the four main components (10 μg/mL) can significantly stimulate intestinal bacteria to produce short chain fatty acids in vitro, respectively, which can further contribute to the effect in myocardial ischemia. In this study, the therapeutic effect against myocardial ischemia of Saussurea involucrata was first reported to be related to the intestinal flora, which can be useful in understanding the effective substances of Saussurea involucrata.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (2021-I2M-1-028, 2021-I2M-1-027, 2021-I2M-1-007, 81973290, 82173888, Z141102004414062)
- National Natural Science Foundation of China (2021-I2M-1-028, 2021-I2M-1-027, 2021-I2M-1-007, 81973290, 82173888, Z141102004414062)
- Beijing Key Laboratory of Non-Clinical Drug Metabolism (2021-I2M-1-028, 2021-I2M-1-027, 2021-I2M-1-007, 81973290, 82173888, Z141102004414062)
This publication has 76 references indexed in Scilit:
- 3,4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-κB signalingBMC Complementary and Alternative Medicine, 2014
- The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43Nature Communications, 2013
- Qualitative and quantitative analysis of phenylpropanoids in cell culture, regenerated plantlets and herbs of Saussurea involucrataJournal of Pharmaceutical and Biomedical Analysis, 2012
- Gut microbiome, obesity, and metabolic dysfunctionJournal of Clinical Investigation, 2011
- Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Nature, 2009
- Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic ratsJournal of Pharmacy and Pharmacology, 2009
- Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in MiceDiabetes, 2009
- Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in DogsCirculation, 2008
- Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequencesAmino Acids, 2006
- Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic ratsCanadian Journal of Physiology and Pharmacology, 2005